EP3302499
Meðhöndlun á hvatberasjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.6.2016EP published:
15.3.2023EP application number:
16728892.7
EP translation filed:
8.5.2023Grant published:
15.6.2023EPO information:
European Patent Register
Max expiry date:
2.6.2036Expiry date:
2.6.2026Next due date:
30.6.2026
Title in English:
TREATMENT OF MITOCHONDRIAL DISEASESLanguage of the patent:
English
Timeline
Today
3.6.2016EP application
15.3.2023EP Publication
8.5.2023Translation submitted
15.6.2023Registration published
2.6.2026Expires
Owner
Name:
Fundació Hospital Universitari Vall d'Hebron - Institut de RecercaAddress:
Passeig Vall d'Hebrón, 119-129, 08035 Barcelona, ES
Name:
Centro de Investigación Biomédica en Red (CIBER)Address:
Instituto de Salud Carlos III Pabellón 11. planta baja C/Monforte de Lemos 3-5, 28029 Madrid, ES
Inventor
Name:
MARTÍ SEVES, RamonAddress:
08012 Barcelona, ES
Name:
GONZÁLEZ VIOQUE, EmilianoAddress:
28021 Madrid, ES
Name:
BLÁZQUEZ BERMEJO, CoraAddress:
20100 Errenteria, ES
Name:
TORRES TORRONTERAS, JavierAddress:
08820 El Prat De Llobregat, ES
Name:
CABRERA PÉREZ, RaquelAddress:
08830 Sant Boi De Llobregat, ES
Name:
CÁMARA NAVARRO, YolandaAddress:
08030 Barcelona, ES
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15170825Date:
5.6.2015Country:
EP
Classification
Categories:
A61K 31/7052, A61K 31/7084, A61K 31/7088, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.5.2023
Expires: 2.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.5.2024
Expires: 2.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 30.5.2025
Expires: 2.6.2026
Payer: Árnason Faktor ehf.